Navigation Links
Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
Date:2/14/2011

LOS ANGELES, Feb. 14, 2011 /PRNewswire/ -- A report on the California biomedical industry published last week by the California Healthcare Institute (CHI) highlights success stories from Larta Institute, a consulting firm that helps government-funded emerging entrepreneurs bring their technologies from lab to market.

According to CHI's 2011 California Biomedical Industry Report, the industry has become a growing force in the past few years in the state, despite the overall decline in the economy. Much of the industry growth can be attributed to the emergence of new biomedical ventures, as well as government funds supporting California's life sciences companies. In 2010, this resulted in the development of 876 products in California alone, making up 12% of the total worldwide biopharmaceutical product development pipeline.

The report features five successful California companies that have participated in the Larta-managed National Institutes of Health Commercialization Assistance Program (NIH-CAP): a 10-month mentoring and partnering-oriented effort geared to accelerate the commercial and market readiness of award-winning life science companies supported by NIH institutes across a variety of health care areas. One success story includes the San Francisco biomedical company, Wave 80 BioSciences. In 2007, this company developed a handheld diagnostic device for malaria, and is currently working on a similar technology to detect HIV in newborns. Wave 80 participated in Larta's NIH-CAP, and upon completion, was awarded a $7.5 million contract by the National Institute of Allergy and Infectious Diseases.

Larta has mentored more than 700 NIH-funded companies since the organization began managing the NIH-CAP in 2004. Larta has also assisted 105 NIH-CAP companies raise over $397 million in capital, and has had 10 acquisitions result from the program. Larta's commercialization programs are designed to support early stage entrepreneurs and drive entrepreneurship across the nation. In addition to NIH, Larta also partners with the National Science Foundation (NSF), U.S. Department of Agriculture (USDA) and Department of Energy (DOE).

About Larta Institute

Larta is a professional services firm that helps turn government-funded innovations into enterprises. Our clients range from federal agencies in the U.S. to governments and regional authorities across the globe. We increase the market and investor readiness of emerging entrepreneurs supported by these institutions. Larta has over 17 years of experience designing and managing customized mentoring programs to help innovators reach commercial markets. We credit our proven track record of success to our unrivaled expertise and extensive global network of subject-matter experts, seasoned entrepreneurs, investors, and Fortune 1000 companies. Since 1993, we have assisted hundreds of entrepreneurs to raise over $1.5 billion in capital.Media ContactRebecca Lauber
Programs and Business Development Associate
rlauber@larta.org
213.538.1445This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Larta Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
3. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
4. Cyntellect to Collaborate With the Burnham Institute for Medical Research
5. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
6. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
9. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
10. Annual List of Best Doctors in Dallas Showcases Texas Institute for Surgery Physicians
11. LifeModeler, Inc. Provides $400,000 Grant to InMotion Musculoskeletal Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... India , February 17, 2017 ... report "Biomarkers Market by Product (Consumables, Service), Type ... Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) ... the market is projected to reach USD 53.34 ... 2016, growing at a CAGR of 13.8% during ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has ... at the agricultural industry. Pilot studies are about to get under way for the ... Data and 5G innovations. The concept is expected to be transferred eventually to other ...
(Date:2/16/2017)... Calif. , Feb. 16, 2017  ArmaGen, ... developing groundbreaking therapies to treat severe neurological disorders, ... children treated with AGT-181, the company,s investigational therapy ... (also known as mucopolysaccharidosis type I, or MPS ... 2 proof-of-concept (POC) study, presented today at the ...
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) becomes the ... management. In addition to optimizing care coordination for patients ... UCHealth looks to improve provider workflow by decreasing the ... Stephanie Brown, RN , Thoracic Nurse Navigator, says, "I ... spreadsheet, which was extremely arduous and susceptible to error.  ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):